Statistical analysis plan for the Dex-CSDH trial: a randomised, double-blind, placebo-controlled trial of a 2-week course of dexamethasone for adult patients with a symptomatic chronic subdural haematoma.

MLA

Allison, Annabel, et al. “Statistical Analysis Plan for the Dex-CSDH Trial: A Randomised, Double-Blind, Placebo-Controlled Trial of a 2-Week Course of Dexamethasone for Adult Patients with a Symptomatic Chronic Subdural Haematoma.” Trials, vol. 20, no. 1, Dec. 2019, pp. 1–5. EBSCOhost, https://doi.org/10.1186/s13063-019-3866-6.

APA

Allison, A., Edlmann, E., Kolias, A. G., Davis-Wilkie, C., Mee, H., Thelin, E. P., Turner, C., Hutchinson, P. J., & Bond, S. (2019). Statistical analysis plan for the Dex-CSDH trial: a randomised, double-blind, placebo-controlled trial of a 2-week course of dexamethasone for adult patients with a symptomatic chronic subdural haematoma. Trials, 20(1), 1–5. https://doi.org/10.1186/s13063-019-3866-6

Chicago

Allison, Annabel, Ellie Edlmann, Angelos G. Kolias, Carol Davis-Wilkie, Harry Mee, Eric P. Thelin, Carole Turner, Peter J. Hutchinson, and Simon Bond. 2019. “Statistical Analysis Plan for the Dex-CSDH Trial: A Randomised, Double-Blind, Placebo-Controlled Trial of a 2-Week Course of Dexamethasone for Adult Patients with a Symptomatic Chronic Subdural Haematoma.” Trials 20 (1): 1–5. doi:10.1186/s13063-019-3866-6.